[PLX] YoY Annual Result on 31-Dec-2011 [#FY]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
27-Feb-2012
Financial Year
2011
Quarter
31-Dec-2011 [#FY]
Profit Trend
YoY- -25.97%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Annual Result
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Revenue 15,160 11,513 34,424 8,386 6,642 388 0 -
PBT -29,943 -27,790 -11,618 2 28,998 31,440 22,414 -
Tax -2,944 0 0 43,306 48,792 62,880 44,828 -
NP -29,943 -27,790 -11,618 -36,529 -28,998 -31,440 -22,414 4.94%
Tax Rate - - - -2,165,300.00% -168.26% -200.00% -200.00% -
Total Cost 45,103 39,303 46,042 44,915 35,640 31,828 22,414 12.35%
Ratio Analysis
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
NP Margin -197.51 -241.38 -33.75 -435.60 -436.59 -8,103.09 0.00 -
Per Share
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
EPS -0.32 -0.30 -0.13 -0.43 -0.36 -0.41 -0.30 1.08%
EPS Diluted -0.32 -0.30 -0.13 -0.43 -0.36 -0.41 -0.30 1.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.